A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. uri icon

authors

  • Salloway, Stephen
  • Andrew Aschenbrenner, PhD
  • Hassenstab, Jason
  • Benzinger, Tammie L S
  • Gordon, Brian A
  • Fagan, Anne M
  • Coalier, Kelley A
  • Cruchaga, Carlos
  • Goate, Alison A
  • Perrin, Richard J
  • Xiong, Chengjie
  • Farlow, Martin
  • Li, Yan
  • Morris, John C
  • Snider, B Joy
  • Mummery, Catherine
  • Surti, G Mustafa
  • Hannequin, Didier
  • Wallon, David
  • Berman, Sarah B
  • Lah, James J
  • Jimenez-Velazquez, Ivonne Z
  • McDade, Eric
  • Roberson, Erik D
  • van Dyck, Christopher H
  • Honig, Lawrence S
  • Sánchez-Valle, Raquel
  • Brooks, William S
  • Gauthier, Serge
  • Galasko, Douglas R
  • Masters, Colin L
  • Brosch, Jared R
  • Hsiung, Ging-Yuek Robin
  • Clifford, David B
  • Jayadev, Suman
  • Formaglio, Maité
  • Masellis, Mario
  • Clarnette, Roger
  • Pariente, Jérémie
  • Dubois, Bruno
  • Pasquier, Florence
  • Jack, Clifford R
  • Koeppe, Robert
  • Snyder, Peter J
  • Wang, Guoqiao
  • Aisen, Paul S
  • Thomas, Ronald G
  • Berry, Scott M
  • Wendelberger, Barbara A
  • Andersen, Scott W
  • Holdridge, Karen C
  • Mintun, Mark A
  • Yaari, Roy
  • Sims, John R
  • Baudler, Monika
  • Llibre-Guerra, Jorge J
  • Delmar, Paul
  • Doody, Rachelle S
  • Fontoura, Paulo
  • Giacobino, Caroline
  • Kerchner, Geoffrey A
  • Bateman, Randall J
  • Hitchcock, Janice M
  • Mills, Susan L
  • Santacruz, Anna M

publication date

  • January 1, 2021